TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension

Clinical trial NCT00576251 · COMPLETED

Trial details

NCT number: NCT00576251
Sponsor: Alcon Research
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ocular Inflammation Associated With Blepharaconjunctivitis

Start date: 2007-10-01
Primary completion: 2008-02-01
Enrollment: 221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.